参考文献/References:
[1] OMBRELLO M J,KIRINO Y,DE BAKKER P I,GL A,KASTNER D L,REMMERS E F.Behet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity[J].Proc Natl Acad Sci USA,2014,111(24):8867-8872.
[2] XAVIER J M,DAVATCHI F,ABADE O,SHAHRAM F,FRANCISCO V,ABDOLLAHI BS,et al.Characterization of the major histocompatibility complex locus association with Behet’s disease in Iran[J].Arthrit Res Ther,2015,17:81.
[3] TAKEUCHI M,MIZUKI N,MEGURO A,OMBRELLO MJ,KIRINO Y,SATORIUS C,et al.Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behet’s disease susceptibility[J].Nat Genet,2017,49(3):438-443.
[4] LEE Y H,CHOI S J,JI J D,SONG G G.Genome-wide pathway analysis of a genome-wide association study on psoriasis and Behcet’s disease[J].Mol Biol Rep,2012,39(5):5953-5959.
[5] OMBRELLO M J,KIRINO Y,DE BAKKER P I,GüL A,KASTNER D L,REMMERS E F.Behet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity[J].Proc Natl Acad Sci USA,2014,111(24):8867-8872.
[6] JANG W C,NAM Y H,AHN Y C,LEE S H,PARK S H,CHOE JY,et al.Interleukin-17F gene polymorphisms in Korean patients with Behet’s disease[J].Rheumatol Int,2008,29(2):173-178.
[7] TALAAT R M,ASHOUR M E,BASSYOUNI I H,RAOUF A A.Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet’s disease[J].Immunobiology,2014,219(8):573-582.
[8] HU J,HOU S,ZHU X,FANG J,ZHOU Y,LIU Y,et al.Interleukin-10 gene polymorphisms are associated with Behcet’s disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population[J].Mol Vis,2015,21:589-603.
[9] DEHGHANZADEH R,BABALOO Z,SAKHINIA E,KHABAZI A,SHANEHBANDI D,SADIGH-ETEGHAD S,et al.IL-27 Gene Polymorphisms in Iranian Patients with Behcet’s Disease[J].Clin Lab,2016,62(5):855-861.
[10] XIANG Q,CHEN L,HOU S,FANG J,ZHOU Y,BAI L,et al.TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behet’s disease and Vogt-Koyanagi-Harada syndrome:a case-control study[J].PLoS One,2014,9(1):e84214.
[11] HOU S,XIAO X,LI F,JIANG Z,KIJLSTRA A,YANG P.Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behcet’s disease susceptibility[J].Human Genet,2012,131(12):1841-1850.
[12] HOU S,XIAO X,ZHOU Y,ZHU X,LI F,KIJLSTRA A,et al.Genetic variant on PDGFRL associated with Behet disease in Chinese Han populations[J].Human Mutat,2013,34(1):74-78.
[13] ABDEL GALIL S M,HAGRASS H A.The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in Egyptian patients with Behcet’s disease[J].Biomed Res Int,2014,2014:513915.
[14] ZHENG X,WANG D,HOU S,ZHANG C,LEI B,XIAO X,et al.Association of macrophage migration inhibitory factor gene polymorphisms with Behcet’s disease in a Han Chinese population[J].Ophthalmology,2012,119(12):2514-2518.
[15] KARASNEH J A,HAJEER A H,SILMAN A,WORTHINGTON J,OLLIER WE,GUL A.Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behet’s disease[J].Rheumatology(Oxford),2005,44(5):614-617.
[16] CHMAISSE H N,FAKHOURY H A,SALTI N N,MAKKI R F.The ICAM-1(469 T/C) gene polymorphism but not(241 G/A) is associated with Behcet`s disease in the Lebanese population[J].Neurosciences(Riyadh),2006,11(3):187-190.
[17] LEE Y J,HORIE Y,WALLACE G R,CHOI Y S,PARK J A,CHOI J Y,et al.Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet’s disease[J].Ann Rheum Dis,2013,72(9):1510-1516.
[18] XAVIER J M,KRUG T,DAVATCHI F,SHAHRAM F,FONSECA B V,JESUS G,et al.Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behcet’s disease susceptibility[J].J Mol Med,2013,91(8):1013-1023.
[19] HOU S,YANG Z,DU L,JIANG Z,SHU Q,CHEN Y,et al.Identification of a susceptibility locus in STAT4 for Behet’s disease in Han Chinese in a genome-wide association study[J].Arthrit Rheumatol,2012,64(12):4104-4113.
[20] HOU S,QI J,ZHANG Q,LIAO D,LI Q,HU K,et al.Genetic variants in the JAK1 gene confer higher risk of Behcet’s disease with ocular involvement in Han Chinese[J].Human Genet,2013,132(9):1049-1058.
[21] ZHANG L,YU H,ZHENG M,LI H,LIU Y,KIJLSTRA A,et al.Association of ERAP1 gene polymorphisms with Behcet’s disease in Han Chinese[J].Invest Ophthalmol Vis Sci,2015,56(10):6029-6035.
[22] SAWALHA A H,HUGHES T,NADIG A,YILMAZ V,AKSU K,KESER G,et al.A putative functional variant within the UBAC2 gene is associated with increased risk of Behcet’s disease[J].Arthrit Rheumatol,2011,63(11):3607-3612.
[23] ZHENG M,YU H,ZHANG L,LI H,LIU Y,KIJLSTRA A,et al.Association of ATG5 gene polymorphisms with Behcet’s disease and ATG10 gene polymorphisms with VKH syndrome in a Chinese Han population[J].Invest Ophthalmol Vis Sci,2015,56(13):8280-8287.
[24] HOU S,SHU Q,JIANG Z,CHEN Y,LI F,CHEN F,et al.Replication study confirms the association between UBAC2 and Behet’s disease in two independent Chinese sets of patients and controls[J].Arthrit Res Thera,2012,14(2):R70.
[25] LI H,LIU Q,HOU S,DU L,ZHOU Q,ZHOU Y,et al.TNFAIP3 gene polymorphisms confer risk for Behcet’s disease in a Chinese Han population[J].Human Genet,2013,132(3):293-300.
[26] COSKUND T,COITP A O,ALPSOYE D.TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism is not increased in Behet’s disease patients in two ethnic cohorts[J].Clin Exp Rheumatol,2013,31(3):54-56.
[27] DURRANI O,BANAHAN K,SHEEDY F J,MCBRIDE L,BEN-CHETRIT E,GREINER K,et al.TIRAP Ser180Leu polymorphism is associated with Behcet’s disease[J].Rheumatology,2011,50(10):1760-1765.
[28] HOSSEINI A,SHANEHBANDI D,ESTIAR M A,GHOLIZADEH S,KHABBAZI A,KHODADADI H,et al.A Single Nucleotide Polymorphism in the FOXP3 Gene Associated with Behet’s Disease in an Iranian Population[J].Clin Lab,2015,61(12):1897-1903.
[29] ORTIZ-FERNáNDEZ L,GARCíA-LOZANO JR,MONTES-CANO M A,CONDE-JALDóN M,ORTEGO-CENTENO N,GARCíA-HERNáNDEZ FJ,et al.Lack of association of TNFAIP3 and JAK1 with Behet’s disease in the European population[J].Clin Exp Rheumatol,2015,33(6 Suppl 94):S36-39.
[30] CHEN Y,VAUGHAN R W,KONDEATIS E,FORTUNE F,GRAHAM E M,STANFORD M R,et al.Chemokine gene polymorphisms associate with gender in patients with uveitis[J].Tissue Antigens,2004,63(1):41-45.
[31] HU K,YANG P,JIANG Z,HOU S,DU L,LI F.STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behet’s disease[J].Hum Immunol,2010,71(7):723-726.
[32] OHNO S.Immunological aspects of Behet’s and Vogt-Koyanagi-Harada’s diseases[J].Trans Ophthalmol Soc UK,1981,101(Pt 3)(3):335-341.
[33] SHINDO Y,OHNO S,YAMAMOTO T,NAKAMURA S,INOKO H.Complete association of the HLA-DRB1*04 and-DQB1*04 alleles with Vogt-Koyanagi-Harada’s disease[J].Hum Immunol,1994,39(3):169-176.
[34] HU K,HOU S,LI F,XIANG Q,KIJLSTRA A,YANG P.JAK1,but not JAK2 and STAT3,confers susceptibility to Vogt-Koyanagi-Harada(VKH) syndrome in a Han Chinese population[J].Invest Ophthalmol Vis Sci,2013,54(5):3360-3365.
[35] LI K,HOU S,QI J,KIJLSTRA A,YANG P.A variant of CLEC16A gene confers protection for Vogt-Koyanagi-Harada syndrome but not for Behcet’s disease in a Chinese Han population[J].Exp Eye Res,2015,132:225-230.
[36] CAO S,CHEE SP,YU HG,SUKAVATCHARIN S,WU L,KIJLSTRA A,et al.Investigation of the association of Vogt-Koyanagi-Harada syndrome with IL23R-C1orf141 in Han Chinese Singaporean and ADO-ZNF365-EGR2 in Thai[J].Br J Ophthalmol,2016,100(3):436-442.
[37] LAN C,TAM P O,CHIANG SW,CHAN C K,LUK F O,LEE G K,et al.Manganese superoxide dismutase and chemokine genes polymorphisms in chinese patients with anterior uveitis[J].Invest Ophthalmol Vis Sci,2009,50(12):5596-5600.
[38] XIANG Q,CHEN L,FANG J,HOU S,WEI L,BAI L,et al.TNF receptor-associated factor 5 gene confers genetic predisposition to acute anterior uveitis and pediatric uveitis[J].Arthrit Res Ther,2013,15(5):R113.
[39] WANG Y,HUANG X F,YANG M M,CAI W J,ZHENG M Q,MAO G,et al.CFI-rs7356506 is a genetic protective factor for acute anterior uveitis in Chinese patients[J].Br J Ophthalmol,2014,98(11):1592-1596.
[40] LI H,HOU S,YU H,ZHENG M,ZHANG L,ZHANG J,et al.Association of genetic variations in TNFSF15 with acute anterior uveitis in Chinese Han[J].Invest Ophthalmol Vis Sci,2015,56(8):4605-4610.
[41] XU D,HOU S,JIANG Y,ZHANG J,CAO S,ZHANG D,et al.Complement C5 gene confers risk for acute anterior uveitis[J].Invest Ophthalmol Vis Sci,2015,56(8):4954-4960.
相似文献/References:
[1]唐耀冰 陈桂英 王晓艳 侯明佳.玻璃体内注射Infliximab治疗大鼠葡萄膜炎的实验研究[J].眼科新进展,2013,33(7):000.
[2]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[3]刘莹 李林 高晓唯.肿瘤坏死因子拮抗剂在葡萄膜炎治疗中的应用[J].眼科新进展,2012,32(1):000.
[4]刘莹 李林 高晓唯 张振华 杨永利 赵旭东.玻璃体内注射 Infliximab对实验性自身免疫性葡萄膜炎的治疗作用[J].眼科新进展,2012,32(2):000.
[5]陈海婷,王红.生物制剂在葡萄膜炎治疗中的应用[J].眼科新进展,2010,30(5):000.
[6]杨婷婷,邓娟,梁雪梅. 葡萄膜炎患者血清胆红素、尿酸及白蛋白浓度分析[J].眼科新进展,2014,34(4):358.[doi:10.13389/j.cnki.rao.2014.0097]
[7]于晋懿,卢弘. 非感染性葡萄膜炎的免疫抑制治疗[J].眼科新进展,2014,34(7):695.[doi:10.13389/j.cnki.rao.2014.0191]
[8]郭建全.曲安奈德对年龄相关性白内障术后前葡萄膜炎的疗效及其对炎症因子的影响[J].眼科新进展,2014,34(8):769.[doi:10.13389/j.cnki.rao.2014.0212]
GUO Jian-Quan.Efficacy of triamcinolone acetonide for anterior uveitis after age-related cataract surgery and its impact on inflammatory cytokines[J].Recent Advances in Ophthalmology,2014,34(8):769.[doi:10.13389/j.cnki.rao.2014.0212]
[9]张莲,毕宏生,郭俊国.抗TNF生物制剂在葡萄膜炎临床治疗中的应用进展[J].眼科新进展,2014,34(12):1187.[doi:10.13389/j.cnki.rao.2014.0330]
ZHANG Lian,BI Hong-Sheng,GUO Jun-Guo.Application progress of anti-TNF biologic agents for uveitis[J].Recent Advances in Ophthalmology,2014,34(8):1187.[doi:10.13389/j.cnki.rao.2014.0330]
[10]金鑫,金昊,张红. 幼年特发性关节炎并发葡萄膜炎的治疗新进展[J].眼科新进展,2015,35(6):585.[doi:10.13389/j.cnki.rao.2015.0159]
JIN Xin,JIN Hao,ZHANG Hong. Treatment advances in uveitis associated with juvenile idiopathic arthriti[J].Recent Advances in Ophthalmology,2015,35(8):585.[doi:10.13389/j.cnki.rao.2015.0159]
[11]张沐,康丽华,管怀进.MicroRNA相关单核苷酸多态性与眼部疾病关系的研究进[J].眼科新进展,2014,34(11):1083.[doi:10.13389/j.cnki.rao.2014.0301]
ZHANG Mu,KANG Li-Hua,GUAN Huai-Jin.Recent advances in relationship between microRNA-related SNPs and ocular diseases[J].Recent Advances in Ophthalmology,2014,34(8):1083.[doi:10.13389/j.cnki.rao.2014.0301]